Skip to main content

Pharmacogenetics and Drug Development

Buy Article:

$32.00 plus tax (Refund Policy)

Abstract:

This chapter examines the application of pharmacogenetics to drug development. It explains why there has been a recent slowdown in discovery and development of new medicines and how pharmacogenetics may help address this problem. It discusses how application of genetic biomarkers will affect drug development. Such an approach can, in principle, reduce the costs of clinical trials for prospective medicines while increasing the probability that potential products might reach the market.

Document Type: Review Article

Publication date: 2009-11-01

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more